Haleon is to axe diversity targets from its executive bonus scheme in the latest sign that UK businesses are rowing back on ...

Illumina & NashBio announce Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery: San Diego Friday, March 21, 2025, 10:00 Hrs [IST] Illumina ...

AstraZeneca Plc will invest $2.5 billion in a new research center in Beijing, in a major show of commitment to China just ...

About three months after leaving her post as the FDA’s principal deputy commissioner, Namandjé Bumpus, Ph.D., has found a new ...

Zai Lab Limited's stock surged 105% in a year. Click to explore ZLAB's $2bn revenue goal, key drugs, and strategic ...

Greg Bradley has 34 years of experience in the consumer-packaged goods industry, with specific expertise in over-the-counter ...

The pharma is spending $2.5 billion on an R&D center in Beijing. Elsewhere, Adaptimmune warned it could run out of cash and Pfizer sold its remaining stake in Haleon.

Vanderbilt University Medical Center subsidiary genomic data company Nashville Biosciences and San Diego-based Illumina have announced that they have sequenced 250,000 whole genomes, according to a ...

The growing preference for plant-based and naturally derived pharmaceuticals is fueling the expansion of the Natural APIs ...

Richard Wyatt, Chairman of Temple Bar Investment Trust comments: “I am pleased to report that the Trust has again outperformed its Benchmark, the FTSE All-Share Index, by a significant margin. The Net ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.